These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
456 related articles for article (PubMed ID: 19453367)
21. Prognostic factors for radiation treatment of mast cell tumor in 85 dogs. Turrel JM; Kitchell BE; Miller LM; Théon A J Am Vet Med Assoc; 1988 Oct; 193(8):936-40. PubMed ID: 3142828 [TBL] [Abstract][Full Text] [Related]
22. Association of Ki67 index with prognosis for intermediate-grade canine cutaneous mast cell tumours. Maglennon GA; Murphy S; Adams V; Miller J; Smith K; Blunden A; Scase TJ Vet Comp Oncol; 2008 Dec; 6(4):268-74. PubMed ID: 19178685 [TBL] [Abstract][Full Text] [Related]
23. The utility of staging in canine mast cell tumours. Warland J; Amores-Fuster I; Newbury W; Brearley M; Dobson J Vet Comp Oncol; 2014 Dec; 12(4):287-98. PubMed ID: 23240829 [TBL] [Abstract][Full Text] [Related]
25. Impact of primary tumour stage on survival in dogs with solitary lung tumours. Polton GA; Brearley MJ; Powell SM; Burton CA J Small Anim Pract; 2008 Feb; 49(2):66-71. PubMed ID: 17725584 [TBL] [Abstract][Full Text] [Related]
26. Correlation of DNA ploidy to tumor histologic grade, clinical variables, and survival in dogs with mast cell tumors. Ayl RD; Couto CG; Hammer AS; Weisbrode S; Ericson JG; Mathes L Vet Pathol; 1992 Sep; 29(5):386-90. PubMed ID: 1413405 [TBL] [Abstract][Full Text] [Related]
27. Ultrasound-guided cytology of spleen and liver: a prognostic tool in canine cutaneous mast cell tumor. Stefanello D; Valenti P; Faverzani S; Bronzo V; Fiorbianco V; Pinto da Cunha N; Romussi S; Cantatore M; Caniatti M J Vet Intern Med; 2009; 23(5):1051-7. PubMed ID: 19656285 [TBL] [Abstract][Full Text] [Related]
28. Treating the locoregional lymph nodes with radiation and/or surgery significantly improves outcome in dogs with high-grade mast cell tumours. Mendez SE; Drobatz KJ; Duda LE; White P; Kubicek L; Sorenmo KU Vet Comp Oncol; 2020 Jun; 18(2):239-246. PubMed ID: 31509648 [TBL] [Abstract][Full Text] [Related]
29. Association of argyrophilic nucleolar organizing regions, Ki-67, and proliferating cell nuclear antigen scores with histologic grade and survival in dogs with soft tissue sarcomas: 60 cases (1996-2002). Ettinger SN; Scase TJ; Oberthaler KT; Craft DM; McKnight JA; Leibman NF; Charney SC; Bergman PJ J Am Vet Med Assoc; 2006 Apr; 228(7):1053-62. PubMed ID: 16579784 [TBL] [Abstract][Full Text] [Related]
30. The prognostic value of lymph node metastasis with grade 2 MCTs in dogs: 55 cases (2001-2010). Baginski H; Davis G; Bastian RP J Am Anim Hosp Assoc; 2014; 50(2):89-95. PubMed ID: 24446400 [TBL] [Abstract][Full Text] [Related]
31. Recurrence rates and sites for grade II canine cutaneous mast cell tumors following complete surgical excision. Weisse C; Shofer FS; Sorenmo K J Am Anim Hosp Assoc; 2002; 38(1):71-3. PubMed ID: 11804319 [TBL] [Abstract][Full Text] [Related]
32. Dose-escalating vinblastine for the treatment of canine mast cell tumour. Vickery KR; Wilson H; Vail DM; Thamm DH Vet Comp Oncol; 2008 Jun; 6(2):111-9. PubMed ID: 19178670 [TBL] [Abstract][Full Text] [Related]
33. Relationships between the histological grade of cutaneous mast cell tumours in dogs, their survival and the efficacy of surgical resection. Murphy S; Sparkes AH; Smith KC; Blunden AS; Brearley MJ Vet Rec; 2004 Jun; 154(24):743-6. PubMed ID: 15224593 [TBL] [Abstract][Full Text] [Related]
34. The impact of extirpation of non-palpable/normal-sized regional lymph nodes on staging of canine cutaneous mast cell tumours: A multicentric retrospective study. Ferrari R; Marconato L; Buracco P; Boracchi P; Giudice C; Iussich S; Grieco V; Chiti LE; Favretto E; Stefanello D Vet Comp Oncol; 2018 Dec; 16(4):505-510. PubMed ID: 29893066 [TBL] [Abstract][Full Text] [Related]
35. Lymph node staging of oral and maxillofacial neoplasms in 31 dogs and cats. Herring ES; Smith MM; Robertson JL J Vet Dent; 2002 Sep; 19(3):122-6. PubMed ID: 12382529 [TBL] [Abstract][Full Text] [Related]
36. Lymphadenectomy improves outcome in dogs with resected Kiupel high-grade cutaneous mast cell tumours and overtly metastatic regional lymph nodes. Chalfon C; Sabattini S; Finotello R; Faroni E; Guerra D; Pisoni L; Ciammaichella L; Vasconi ME; Annoni M; Marconato L J Small Anim Pract; 2022 Sep; 63(9):661-669. PubMed ID: 35733233 [TBL] [Abstract][Full Text] [Related]
37. Magnetic resonance imaging of canine mast cell tumors. Pokorny E; Hecht S; Sura PA; LeBlanc AK; Phillips J; Conklin GA; Haifley KA; Newkirk K Vet Radiol Ultrasound; 2012; 53(2):167-73. PubMed ID: 22136427 [TBL] [Abstract][Full Text] [Related]
38. Expression of serotonin and its 5-HT1A receptor in canine cutaneous mast cell tumours. Fröberg GK; Lindberg R; Ritter M; Nordlind K J Comp Pathol; 2009; 141(2-3):89-97. PubMed ID: 19446835 [TBL] [Abstract][Full Text] [Related]
39. Histological grading and prognosis in dogs with mammary carcinomas: application of a human grading method. Karayannopoulou M; Kaldrymidou E; Constantinidis TC; Dessiris A J Comp Pathol; 2005 Nov; 133(4):246-52. PubMed ID: 16202421 [TBL] [Abstract][Full Text] [Related]
40. Adverse haematological effects of vinblastine, prednisolone and cimetidine treatment: a retrospective study in fourteen dogs with mast cell tumours. Trumel C; Bourgès-Abella N; Touron C; Lanore D; Geffré A; Diquelou A; Guelfi JF; Braun JP J Vet Med A Physiol Pathol Clin Med; 2005 Aug; 52(6):275-9. PubMed ID: 16050908 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]